Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gareth R Evans

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|September 13, 2022
A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannomaChay Paterson, Ivana Bozic, Miriam J Smith, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 9, 2005
Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentationAmit Herwadker, Elizabeth A Vokurka, D Gareth R Evans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 9, 2005
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thoughtD Gareth R Evans, Anthony Moran, Andrew King, et al.
Genetic Epidemiology|April 11, 2003
Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma developmentRyan Woods, J M Friedman, D Gareth R Evans, et al.
Journal of the National Cancer Institute|March 10, 2025
Radiotherapy results in decreased time to second cancer in children with Li Fraumeni syndromeEmma R Woodward, John-Paul Kilday, Stephanie Ng, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2011
Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent yearsSarah Ingham, Susan M Huson, Anthony Moran, et al.
Cancer Genetics|June 17, 2014
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumorsMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Breast Cancer Research and Treatment|July 4, 2012
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?Miriam J Smith, Franchesca L Gifford, Fiona Lalloo, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancerRobert D Morgan, Andrew R Clamp, D Gareth R Evans, et al.
Lancet (London, England)|April 4, 2003
Prediction of pathogenic mutations in patients with early-onset breast cancer by family historyFiona Lalloo, Jennifer Varley, David Ellis, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|September 13, 2022
A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannomaChay Paterson, Ivana Bozic, Miriam J Smith, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 9, 2005
Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentationAmit Herwadker, Elizabeth A Vokurka, D Gareth R Evans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 9, 2005
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thoughtD Gareth R Evans, Anthony Moran, Andrew King, et al.
Genetic Epidemiology|April 11, 2003
Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma developmentRyan Woods, J M Friedman, D Gareth R Evans, et al.
Journal of the National Cancer Institute|March 10, 2025
Radiotherapy results in decreased time to second cancer in children with Li Fraumeni syndromeEmma R Woodward, John-Paul Kilday, Stephanie Ng, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2011
Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent yearsSarah Ingham, Susan M Huson, Anthony Moran, et al.
Cancer Genetics|June 17, 2014
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumorsMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Breast Cancer Research and Treatment|July 4, 2012
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?Miriam J Smith, Franchesca L Gifford, Fiona Lalloo, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancerRobert D Morgan, Andrew R Clamp, D Gareth R Evans, et al.
Lancet (London, England)|April 4, 2003
Prediction of pathogenic mutations in patients with early-onset breast cancer by family historyFiona Lalloo, Jennifer Varley, David Ellis, et al.
Pageof 11